Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT) Regulatory News

Date Source Headline
18th Sep 2019 7:00 am RNS Results for the Six Months ended 30 June 2019
9th Sep 2019 7:00 am RNS Presentation at ICLE 2019
14th Aug 2019 7:00 am RNS Notice of Results
17th Jul 2019 7:00 am RNS Trading Update
11th Jul 2019 7:00 am RNS MaxCyte to Host Capital Markets Day Today
5th Jul 2019 4:42 pm RNS Second Price Monitoring Extn
5th Jul 2019 4:36 pm RNS Price Monitoring Extension
19th Jun 2019 7:00 am RNS Annual Report
12th Jun 2019 7:00 am RNS Appointment of Joint Corporate Broker
29th May 2019 7:00 am RNS Save the Date: Capital Markets Day
8th May 2019 4:41 pm RNS Second Price Monitoring Extn
8th May 2019 4:36 pm RNS Price Monitoring Extension
8th May 2019 7:00 am RNS Phase I Clinical Trial of MCY-M11 Progressed
1st May 2019 7:00 am RNS ASGCT Presentation on First CARMA Drug Candidate
24th Apr 2019 7:00 am RNS Final Results for Year Ended 31 December 2018
8th Apr 2019 7:00 am RNS Launch of ExPERTT Instrument Family
26th Mar 2019 7:00 am RNS Notice of Full Year Results
19th Mar 2019 5:05 pm RNS Director Dealings
5th Mar 2019 7:00 am RNS Grant of Options
1st Mar 2019 7:00 am RNS Clinical & Commercial Agreement with Kite
26th Feb 2019 5:32 pm RNS Result of Special Meeting and Issue of Equity
5th Feb 2019 4:32 pm RNS Results of Placing
5th Feb 2019 7:00 am RNS Proposed Placing to raise a minimum of £10 million
15th Jan 2019 7:00 am RNS Trading Update
19th Dec 2018 7:00 am RNS Change of Auditor
17th Dec 2018 6:06 pm RNS Director Dealings
21st Nov 2018 7:00 am RNS Consolidation of Trading Lines
20th Nov 2018 7:00 am RNS Block Admission Six Monthly Return/TVR
16th Nov 2018 7:00 am RNS Webinar: non-viral cell engineering
14th Nov 2018 7:00 am RNS Clinical and Commercial License Agreement
12th Nov 2018 7:00 am RNS MaxCyte Announces Research Agreement with Kite
9th Nov 2018 7:00 am RNS Expansion of CRISPR Commercial License Agreement
31st Oct 2018 4:25 pm RNS Result of AGM
10th Oct 2018 7:00 am RNS Dosing Begins in First Clinical Trial of MCY-M11
8th Oct 2018 7:00 am RNS Notice of AGM
24th Sep 2018 7:00 am RNS Results for the Half Year ended 30 June 2018
10th Sep 2018 7:00 am RNS Grant of Options
3rd Sep 2018 7:00 am RNS Notice of Half Year Results
26th Jul 2018 5:33 pm RNS Director/PDMR Shareholding
16th Jul 2018 7:00 am RNS FDA IND Clearance for First Clinical Programme
FTSE 100 Latest
Value8,805.44
Change30.75